Edwin Spaans
Impact in
-
- Pharmaceutical studies and practices
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Pharmacogenetics and Drug Metabolism 6
-
- Schizophrenia research and treatment 4
- Bipolar Disorder and Treatment 1
- Co-authors
- Saskia N. de Wildt (5 shared papers)Dick Tibboel (5 shared papers)Janneke N. Samsom (2 shared papers)Pierre A. M. Peeters (6 shared papers)Miriam G. Mooij (2 shared papers)Roger Gaedigk (1 shared paper)Richard B. Kim (1 shared paper)Ute I. Schwarz (1 shared paper)
- Journals
- Clinical Pharmacology & Therapeutics (3 papers)Clinical Pharmacokinetics (2 papers)European Neuropsychopharmacology (2 papers)European Journal of Clinical Pharmacology (2 papers)Drug Metabolism and Disposition (2 papers)
- Partner nations
- NetherlandsUnited StatesBelgium
In The Last Decade
Edwin Spaans
17 papers receiving 482 citations
Peers
Comparison fields: 5 of 61
- Pediatrics, Perinatology and Child Health 146
- Pharmacology 96
- Oncology 76
- Psychiatry and Mental health 53
- Clinical Biochemistry 14
Countries citing papers authored by Edwin Spaans
This map shows the geographic impact of Edwin Spaans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwin Spaans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwin Spaans more than expected).
Fields of papers citing papers by Edwin Spaans
This network shows the impact of papers produced by Edwin Spaans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwin Spaans. The network helps show where Edwin Spaans may publish in the future.
Co-authors
The 25 scholars most cited alongside Edwin Spaans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 119 | |
| 2 | 2019 | 84 | |
| 3 | 2018 | 50 | |
| 4 | 2017 | 45 | |
| 5 | 2002 | 38 | |
| 6 | 2010 | 35 | |
| 7 | 2014 | 30 | |
| 8 | 2011 | 23 | |
| 9 | 2018 | 17 | |
| 10 | 2014 | 16 | |
| 11 | 2008 | 8 | |
| 12 | 2012 | 8 | |
| 13 | 2019 | 8 | |
| 14 | 2012 | 7 | |
| 15 | 2019 | 5 | |
| 16 | 2003 | 2 | |
| 17 | 2010 | 1 |
About Edwin Spaans
Edwin Spaans is a scholar working on Pharmacology, Psychiatry and Mental health, Oncology, Pediatrics, Perinatology and Child Health and Critical Care and Intensive Care Medicine, having authored 17 papers that have together received 496 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (6 papers), Schizophrenia research and treatment (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Mitochondrial Function and Pathology (2 papers), Pharmaceutical studies and practices (2 papers), Cardiovascular Conditions and Treatments (1 paper), Bipolar Disorder and Treatment (1 paper) and Neurotransmitter Receptor Influence on Behavior (1 paper). The work is most often cited by research in Pediatrics, Perinatology and Child Health (146 citations), Pharmacology (96 citations), Oncology (76 citations), Psychiatry and Mental health (53 citations) and Clinical Biochemistry (14 citations). Edwin Spaans has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Saskia N. de Wildt, Dick Tibboel, Janneke N. Samsom, Pierre A. M. Peeters, Miriam G. Mooij, Roger Gaedigk, Richard B. Kim, Ute I. Schwarz, Johannes (Hans) van Goudoever and Jan A.M. Smeitink. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Clinical Pharmacokinetics, European Neuropsychopharmacology, European Journal of Clinical Pharmacology and Drug Metabolism and Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.